Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.51M Sell
37,924
-199,680
-84% -$49.8M 0.02% 373
2025
Q4
$57.2M Buy
237,604
+132,868
+127% +$34M 0.13% 140
2025
Q3
$28.7M Buy
104,736
+55,612
+113% +$15.2M 0.07% 221
2025
Q2
$12.7M Buy
49,124
+2,006
+4% +$479K 0.03% 321
2025
Q1
$10.5M Sell
47,118
-27,135
-37% -$6.33M 0.03% 346
2024
Q4
$17M Buy
74,253
+1,522
+2% +$366K 0.05% 298
2024
Q3
$17.8M Buy
72,731
+52,259
+255% +$11.7M 0.05% 284
2024
Q2
$3.92M Sell
20,472
-5,495
-21% -$1.11M 0.01% 470
2024
Q1
$5.14M Buy
25,967
+841
+3% +$154K 0.02% 441
2023
Q4
$4.32M Sell
25,126
-35,168
-58% -$5.4M 0.02% 489
2023
Q3
$8.92M Sell
60,294
-151,957
-72% -$27.5M 0.04% 363
2023
Q2
$46.4M Buy
212,251
+115,850
+120% +$25.8M 0.19% 113
2023
Q1
$21.1M Buy
96,401
+59,389
+160% +$12.9M 0.09% 219
2022
Q4
$7.7M Sell
37,012
-12,395
-25% -$2.72M 0.04% 355
2022
Q3
$10.8M Sell
49,407
-3,291
-6% -$749K 0.06% 282
2022
Q2
$11M Buy
52,698
+1,366
+3% +$291K 0.06% 286
2022
Q1
$12.4M Sell
51,332
-34,523
-40% -$8.35M 0.05% 300
2021
Q4
$22.4M Sell
85,855
-61,874
-42% -$16.1M 0.07% 245
2021
Q3
$38.9M Sell
147,729
-183,343
-55% -$50.1M 0.14% 172
2021
Q2
$81.6M Buy
331,072
+8,794
+3% +$1.85M 0.15% 165
2021
Q1
$62.5M Buy
322,278
+12,270
+4% +$2.46M 0.13% 193
2020
Q4
$362M Sell
310,008
-16,270
-5% -$3.24M 0.15% 163
2020
Q3
$55.9M Sell
326,278
-41,710
-11% -$7.7M 0.17% 141
2020
Q2
$70.7M Buy
367,988
+235,752
+178% +$38.6M 0.23% 103
2020
Q1
$19.5M Buy
132,236
+28,065
+27% +$4.47M 0.16% 149
2019
Q4
$16.1M Sell
104,171
-22,702
-18% -$3.27M 0.1% 235
2019
Q3
$17.1M Buy
126,873
+81,797
+181% +$10.7M 0.13% 197
2019
Q2
$5.5M Buy
45,076
+503
+1% +$55.7K 0.04% 416
2019
Q1
$4.63M Sell
44,573
-601
-1% -$62K 0.04% 431
2018
Q4
$5.14M Buy
45,174
+2,130
+5% +$228K 0.06% 335
2018
Q3
$4.96M Buy
43,044
+19,494
+83% +$2.14M 0.04% 437
2018
Q2
$2.44M Buy
23,550
+1,048
+5% +$106K 0.02% 566
2018
Q1
$2.21M Sell
22,502
-455
-2% -$43K 0.02% 554
2017
Q4
$1.94M Sell
22,957
-9,776
-30% -$808K 0.02% 607
2017
Q3
$2.52M Buy
32,733
+5,521
+20% +$422K 0.02% 550
2017
Q2
$2.12M Buy
27,212
+1,993
+8% +$143K 0.02% 574
2017
Q1
$1.81M Sell
25,219
-1,075
-4% -$74.3K 0.02% 677
2016
Q4
$1.63M Sell
26,294
-8,610
-25% -$527K 0.02% 693
2016
Q3
$2.26M Sell
34,904
-7,108
-17% -$473K 0.03% 545
2016
Q2
$2.66M Sell
42,012
-920
-2% -$54.2K 0.04% 464
2016
Q1
$2.48M Sell
42,932
-972
-2% -$55K 0.04% 442
2015
Q4
$2.36M Buy
43,904
+11,795
+37% +$665K 0.04% 437
2015
Q3
$1.64M Sell
32,109
-1,276
-4% -$68.7K 0.03% 488
2015
Q2
$1.88M Buy
33,385
+19,357
+138% +$1.22M 0.02% 571
2015
Q1
$1.01M Buy
14,028
+1,629
+13% +$106K 0.01% 730
2014
Q4
$695K Buy
12,399
+4,318
+53% +$225K 0.01% 860
2014
Q3
$398K Sell
8,081
-5,601
-41% -$285K 0.01% 804
2014
Q2
$693K Sell
13,682
-14,660
-52% -$727K 0.01% 837
2014
Q1
$1.27M Hold
28,342
0.02% 603
2013
Q4
$1.33M Sell
28,342
-907
-3% -$45.9K 0.02% 607
2013
Q3
$1.54M Buy
29,249
+13,742
+89% +$667K 0.02% 576
2013
Q2
$700K Buy
+15,507
New +$736K 0.01% 750

Other funds holding RMD

KBC Group's RMD Position: Q1 2026 in Review

KBC Group reduced its ResMed (RMD) stake by 84% in Q1 2026, selling an estimated $49.8M and leaving 37,924 shares worth $8.51M. The position accounts for 0.02% of the portfolio, ranked #373.

KBC Group first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $362M in Q4 2020. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • KBC Group held 37,924 shares of ResMed worth $8.51M as of Q1 2026.
  • KBC Group sold 199,680 ResMed shares in Q1 2026, an estimated $49.8M.
  • ResMed made up 0.02% of KBC Group's portfolio in Q1 2026, its #373 holding.
  • KBC Group first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's ResMed position peaked at $362M in Q4 2020.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.